DETERMINANTS OF HIV DISEASE PROGRESSION - 6-YEAR LONGITUDINAL-STUDY IN THE EDINBURGH HEMOPHILIA HIV COHORT

被引:72
作者
SIMMONDS, P
BEATSON, D
CUTHBERT, RJG
WATSON, H
REYNOLDS, B
PEUTHERER, JF
PARRY, JV
LUDLAM, CA
STEEL, CM
机构
[1] WESTERN GEN HOSP, MRC, HUMAN GENET UNIT, EDINBURGH EH4 2XU, MIDLOTHIAN, SCOTLAND
[2] UNIV EDINBURGH, DEPT MED MICROBIOL, HEPATITIS REFERENCE LAB, EDINBURGH EH8 9YL, MIDLOTHIAN, SCOTLAND
[3] ROYAL INFIRM, DEPT HAEMATOL, EDINBURGH EH3 9HB, MIDLOTHIAN, SCOTLAND
[4] ROYAL INFIRM, REG HAEMOPHILIA CTR, EDINBURGH EH3 9HB, MIDLOTHIAN, SCOTLAND
[5] CENT PUBL HLTH LAB, VIRUS REFERENCE LAB, LONDON NW9 5HT, ENGLAND
基金
英国医学研究理事会;
关键词
D O I
10.1016/0140-6736(91)92029-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Markers of immune function present before infection may determine the subsequent course of disease in HIV-infected individuals. In 1983, we measured immune function in a group of haemophiliacs in Edinburgh. In 1984, 18 of these patients became infected with HIV-1 from contaminated factor VIII. We have followed-up these patients since their seroconversion. The rate of disease progression, as assessed by the appearance or not of Al DS symptoms or signs within five years of seroconversion, was related both to the concentration of total plasma IgM before exposure to infection and to the pattern of specific IgM and IgA anti-HIV response around the time of IgG seroconversion. Disease progression also correlated with concentrations of plasma interleukin-2 receptor (a marker of lymphocyte activation) and with the number and percentage of circulating DR + ve (activated) T cells. Our findings show that the extent of host immune reactivity, which may be genetically determined, is a powerful factor in the pathogenesis of HIV-associated disease.
引用
收藏
页码:1159 / 1163
页数:5
相关论文
共 24 条
  • [1] ASCHER MS, 1990, J ACQ IMMUN DEF SYND, V3, P177
  • [2] CONCURRENT EVOLUTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN PATIENTS INFECTED FROM THE SAME SOURCE - RATE OF SEQUENCE CHANGE AND LOW-FREQUENCY OF INACTIVATING MUTATIONS
    BALFE, P
    SIMMONDS, P
    LUDLAM, CA
    BISHOP, JO
    BROWN, AJL
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (12) : 6221 - 6233
  • [3] BRIEVA JA, 1985, CLIN EXP IMMUNOL, V59, P491
  • [4] CARR R, 1984, LANCET, V1, P1431
  • [5] RELATION BETWEEN HUMORAL RESPONSES TO HIV GAG AND ENV PROTEINS AT SEROCONVERSION AND CLINICAL OUTCOME OF HIV-INFECTION
    CHEINGSONGPOPOV, R
    PANAGIOTIDI, C
    BOWCOCK, S
    ARONSTAM, A
    WADSWORTH, J
    WEBER, J
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1991, 302 (6767): : 23 - 26
  • [6] 5-YEAR PROSPECTIVE-STUDY OF HIV-INFECTION IN THE EDINBURGH HEMOPHILIAC COHORT
    CUTHBERT, RJG
    LUDLAM, CA
    TUCKER, J
    STEEL, CM
    BEATSON, D
    REBUS, S
    PEUTHERER, JF
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1990, 301 (6758): : 956 - 961
  • [7] AIDS - A SYNDROME OF IMMUNE DYSREGULATION, DYSFUNCTION, AND DEFICIENCY
    EDELMAN, AS
    ZOLLAPAZNER, S
    [J]. FASEB JOURNAL, 1989, 3 (01) : 22 - 30
  • [8] HYPER IMMUNOGLOBULIN-M IMMUNODEFICIENCY (DYSGAMMAGLOBULINEMIA) - PRESENCE OF IMMUNOGLOBULIN-M-SECRETING PLASMACYTOID CELLS IN PERIPHERAL-BLOOD AND FAILURE OF IMMUNOGLOBULIN-M-IMMUNOGLOBULIN-G SWITCH IN B-CELL DIFFERENTIATION
    GEHA, RS
    HYSLOP, N
    ALAMI, S
    FARAH, F
    SCHNEEBERGER, EE
    ROSEN, FS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (02) : 385 - 391
  • [9] JONES P, 1983, LANCET, V1, P120
  • [10] A1, CW7, B8, DR3 HLA-ANTIGEN COMBINATION ASSOCIATED WITH RAPID DECLINE OF T-HELPER LYMPHOCYTES IN HIV-1 INFECTION
    KASLOW, RA
    DUQUESNOY, R
    VANRADEN, M
    KINGSLEY, L
    MARRARI, M
    FRIEDMAN, H
    SU, S
    SAAH, AJ
    DETELS, R
    PHAIR, J
    RINALDO, C
    [J]. LANCET, 1990, 335 (8695) : 927 - 930